NO982202L - Eksitatoriske aminosyrederivater - Google Patents

Eksitatoriske aminosyrederivater

Info

Publication number
NO982202L
NO982202L NO982202A NO982202A NO982202L NO 982202 L NO982202 L NO 982202L NO 982202 A NO982202 A NO 982202A NO 982202 A NO982202 A NO 982202A NO 982202 L NO982202 L NO 982202L
Authority
NO
Norway
Prior art keywords
amino acid
acid derivatives
excitatory amino
modulators
amides
Prior art date
Application number
NO982202A
Other languages
English (en)
Norwegian (no)
Other versions
NO982202D0 (no
Inventor
Steven Marc Massey
James Allen Monn
Matthew John Valli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605434.1A external-priority patent/GB9605434D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO982202D0 publication Critical patent/NO982202D0/no
Publication of NO982202L publication Critical patent/NO982202L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO982202A 1995-11-16 1998-05-14 Eksitatoriske aminosyrederivater NO982202L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US686495P 1995-11-16 1995-11-16
GBGB9605434.1A GB9605434D0 (en) 1996-03-15 1996-03-15 Excitatory amino acid derivatives
PCT/US1996/018112 WO1997018199A1 (en) 1995-11-16 1996-11-12 Excitatory amino acid derivatives

Publications (2)

Publication Number Publication Date
NO982202D0 NO982202D0 (no) 1998-05-14
NO982202L true NO982202L (no) 1998-05-14

Family

ID=26308935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982202A NO982202L (no) 1995-11-16 1998-05-14 Eksitatoriske aminosyrederivater

Country Status (22)

Country Link
EP (1) EP0774461B1 (de)
KR (1) KR19990067598A (de)
CN (1) CN1202167A (de)
AR (2) AR006748A1 (de)
AT (1) ATE319685T1 (de)
AU (1) AU703409B2 (de)
BR (1) BR9611511A (de)
CA (1) CA2237910C (de)
CO (1) CO4770955A1 (de)
CZ (1) CZ150198A3 (de)
DE (1) DE69635886T2 (de)
EA (1) EA001617B1 (de)
ES (1) ES2258771T3 (de)
HU (1) HUP9903459A3 (de)
IL (1) IL124487A (de)
NO (1) NO982202L (de)
NZ (1) NZ323205A (de)
PE (1) PE17798A1 (de)
PL (1) PL326695A1 (de)
TR (1) TR199800877T2 (de)
WO (1) WO1997018199A1 (de)
YU (1) YU60796A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014971A1 (de) * 1997-01-29 2000-07-05 Eli Lilly And Company Behandlung von prämenstruelle dysphorische störung
JP2001515839A (ja) 1997-07-18 2001-09-25 ジョージタウン・ユニバーシティ 二環式向代謝性グルタミン酸受容体リガンド
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
DE19801648A1 (de) * 1998-01-17 1999-07-22 Bayer Ag alpha-Substituierte Lactone
DE19801636A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
DE19801647A1 (de) * 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
DE19801646A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
TWI315666B (en) * 2002-06-11 2009-10-11 Lilly Co Eli Prodrugs of excitatory amino acids
WO2010055106A1 (en) * 2008-11-14 2010-05-20 Dsm Fine Chemicals Austria Nfg. Gmbh & Co Kg Process for the production of cyclopropane derivatives
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia
US8735397B2 (en) 2010-03-29 2014-05-27 Vanderbilt University Method for treating schizophrenia and related diseases
KR101598679B1 (ko) 2011-06-17 2016-02-29 일라이 릴리 앤드 캄파니 mGlu2 수용체 효능제로서의 비시클로(3.1.0)헥산-2,6-디카르복실산 유도체
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
PL3096790T3 (pl) * 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (de) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2572842A (en) * 1947-08-05 1951-10-30 Du Pont The n-carboanhydride of 2-amino-4, 6, 6-trimethylheptanoic acid and polymers therefrom
US4536330A (en) * 1982-09-23 1985-08-20 International Flavors & Fragrances Inc. 1-Hydroxymethyl-2-acyl cyclopropane derivatives and esters and cyclic condensation products thereof, organoleptic uses of same and processes for preparing same
ATE206915T1 (de) * 1994-08-12 2001-11-15 Lilly Co Eli Behandlung von angstzuständen
AU3325095A (en) * 1994-08-12 1996-03-07 Eli Lilly And Company Composition and method for protection against drug dependency
PL182285B1 (pl) * 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL

Also Published As

Publication number Publication date
AU7727996A (en) 1997-06-05
YU60796A (sh) 1998-12-23
PL326695A1 (en) 1998-10-26
CA2237910A1 (en) 1997-05-22
NO982202D0 (no) 1998-05-14
CO4770955A1 (es) 1999-04-30
HUP9903459A2 (hu) 2001-04-28
ATE319685T1 (de) 2006-03-15
TR199800877T2 (xx) 1998-09-21
CA2237910C (en) 2005-12-27
IL124487A0 (en) 1998-12-06
AU703409B2 (en) 1999-03-25
BR9611511A (pt) 1999-05-04
EA001617B1 (ru) 2001-06-25
EP0774461A1 (de) 1997-05-21
NZ323205A (en) 1999-06-29
HUP9903459A3 (en) 2001-08-28
CZ150198A3 (cs) 1998-10-14
AR004602A1 (es) 1998-12-16
ES2258771T3 (es) 2006-09-01
IL124487A (en) 2001-01-11
EP0774461B1 (de) 2006-03-08
KR19990067598A (ko) 1999-08-25
PE17798A1 (es) 1998-04-18
AR006748A1 (es) 1999-09-29
EA199800377A1 (ru) 1998-10-29
DE69635886D1 (de) 2006-05-04
DE69635886T2 (de) 2006-10-19
WO1997018199A1 (en) 1997-05-22
CN1202167A (zh) 1998-12-16

Similar Documents

Publication Publication Date Title
NO914356L (no) Mono n-substituerte 1,4,7,10-tetraazacyklododekanderivater, fremgangsmaater for fremstilling av dem og farmasoeytiskemidler som inneholder dem
CA2289472A1 (en) Excitatory amino acid receptor modulators
MX9805289A (es) Nuevos derivados de n-(arilsulfonil)aminoacidos que tienen una afinidad por los receptores de la bradicinina.
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
CA2216796A1 (en) Quinazoline derivatives
IL109144A (en) Glycoprotein IIB/IIIA inhibiting 4-pyridylamino heterocyclic derivatives process for their preparation and pharmaceutical compositions containing them
WO2001032644A3 (en) Excitatory amino acid derivatives
CA2160447A1 (en) Amino(thio)ether derivatives
CA2237910A1 (en) Excitatory amino acid derivatives
MXPA02001340A (es) Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos.
MX9803833A (es) Antagonistas de receptores de aminoacidos excitadores.
MX9706605A (es) Derivados de indol como antagonistas de los aminoacidos exitadores.
NO973652D0 (no) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyre og derivater som tachykininreseptor-antagonist
ATE215821T1 (de) Entzündungshemmende augentropfen
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
MY132585A (en) Excitatory amino acid derivatives
DK0629615T3 (da) Indolderivater som glutamatantagonister
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
AU2986295A (en) N-(amino acid) substituted succinic acid amide derivatives as metalloproteinase inhibitors
CA2168319A1 (en) 4-mercaptobenzoylguanidine derivatives
NO932002L (no) Nye tiosemikarbazonsyreestere
ATE194621T1 (de) Pyrazolothiazolopyrimidin-derivate
MX9803556A (es) Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producirlos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application